|Articles|July 20, 2016
JSS Selects OmniComm TrialMaster EDC
OmniComm Systems announces a three-year agreement with Montreal-based CRO JSS Medical Research.
Advertisement
OmniComm Systems announces a three-year agreement with Montreal-based CRO JSS Medical Research. OmniComm’s TrialMaster platform will be used for the collection of data in numerous clinical trials across global investigative sites.
Read the full release here
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement